DaVita expands renal, diabetes clinical trial services in EU

By Zachary Brennan contact

- Last updated on GMT

DaVita expands renal, diabetes clinical trial services in EU

Related tags: Davita clinical research, Clinical trial

Specialty CRO DaVita Clinical Research has expanded its clinical trials capabilities in Germany, Poland and Portugal. 

Thanks to the expansion, which will include the addition of 10 physician leaders across the three countries, DaVita will be able to conduct late phase clinical trials outside of the US for the first time.

Amy Young, VP and general manager of DaVita Clinical Research, told Outsourcing-Pharma.com that the expansion in Europe will include renal and diabetes clinical trials.

"Combining extensive nephrology and clinical trial experience with knowledge of local differences in the practice of nephrology positions us as a valuable resource in drug development for chronic kidney disease management​," Young added.

In addition to the new work in Europe, DaVita previously conducted Phase I clinical trials in the US since 1985, expanding its capabilities to include late phase clinical research, real-world health care data, health economics and outcomes research and medical communications. The company says it has helped to develop every end stage renal disease drug approved by the US FDA over the last 15 years.

There is increasing demand for global clinical trials​,” Young said. “The ability to provide access in many different countries via a central point of contact, like DaVita Clinical Research, is valuable and desirable for drug and device developers​.” 

Related news

Show more

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 20-Jun-2022 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Governing and Maintaining Clinical Data Standards

Governing and Maintaining Clinical Data Standards

Veeva | 10-May-2022 | Technical / White Paper

Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...

What the Best Clinical Study Build Pros Do

What the Best Clinical Study Build Pros Do

Formedix | 09-May-2022 | Technical / White Paper

Getting your clinical study designed and built ready for data collection takes A LOT of work and expertise… you've got to do all your CRF designs;...

Related suppliers

Follow us

Products

View more

Webinars